Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) Sees Significant Drop in Short Interest

Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) was the target of a large drop in short interest during the month of December. As of December 31st, there was short interest totalling 200 shares, a drop of 33.3% from the December 15th total of 300 shares. Based on an average daily volume of 4,200 shares, the short-interest ratio is presently 0.0 days.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Price Performance

Harrow Health, Inc. 8.625% Senior Notes due 2026 stock traded down $0.34 during mid-day trading on Wednesday, reaching $25.11. 2,783 shares of the company were exchanged, compared to its average volume of 6,364. The company has a fifty day simple moving average of $25.34 and a 200-day simple moving average of $25.37. Harrow Health, Inc. 8.625% Senior Notes due 2026 has a 12 month low of $23.71 and a 12 month high of $25.73.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Wednesday, January 15th will be paid a $0.5391 dividend. This is a positive change from Harrow Health, Inc. 8.625% Senior Notes due 2026’s previous quarterly dividend of $0.54. The ex-dividend date is Wednesday, January 15th. This represents a $2.16 annualized dividend and a dividend yield of 8.59%.

About Harrow Health, Inc. 8.625% Senior Notes due 2026

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.